Nonadherence in the Advanced Heart Failure Population
- PMID: 26879391
- DOI: 10.1007/s11897-016-0287-7
Nonadherence in the Advanced Heart Failure Population
Abstract
The number of patients living with heart failure (HF) in the USA now exceeds 5 million. Although HF is a disease readily treated by medications and lifestyle interventions, nonadherence is common, leading to worse clinical outcomes and increased healthcare costs. While adherence to medical therapy and clinician recommendations is key in the management of HF, it is perhaps more critical in patients with the most advanced disease, including those receiving home inotropic infusion, heart transplantation, or a left ventricular assist device. Yet, there is a paucity of data on the effects of nonadherence on the advanced heart failure population and little information on the most effective management strategies in these patients. Future studies of nonadherence in HF should utilize uniform definitions of adherence and, ideally, more objective measurements of adherence such as the novel "digital pill" technology.
Keywords: Heart failure; Heart transplant; Left ventricular assist device; Nonadherence.
Similar articles
-
Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: design and rationale of the ROADMAP clinical trial.Am Heart J. 2015 Feb;169(2):205-210.e20. doi: 10.1016/j.ahj.2014.11.004. Epub 2014 Nov 11. Am Heart J. 2015. PMID: 25641529 Clinical Trial.
-
Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?J Thorac Cardiovasc Surg. 2014 Sep;148(3):1115-21; discussion 1021-2. doi: 10.1016/j.jtcvs.2014.05.063. Epub 2014 Jun 6. J Thorac Cardiovasc Surg. 2014. PMID: 25129605
-
Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).Circulation. 2004 Aug 24;110(8):975-81. doi: 10.1161/01.CIR.0000139862.48167.23. Epub 2004 Aug 16. Circulation. 2004. PMID: 15313942 Clinical Trial.
-
Treatment of advanced heart failure.Cardiol Rev. 2000 May-Jun;8(3):148-57. Cardiol Rev. 2000. PMID: 11174888 Review.
-
Current indications for heart transplantation and left ventricular assist device: a practical point of view.Eur J Intern Med. 2014 Jun;25(5):422-9. doi: 10.1016/j.ejim.2014.02.006. Epub 2014 Mar 16. Eur J Intern Med. 2014. PMID: 24641806 Review.
Cited by
-
Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure.Curr Heart Fail Rep. 2017 Apr;14(2):78-86. doi: 10.1007/s11897-017-0323-2. Curr Heart Fail Rep. 2017. PMID: 28233258 Review.
-
Performance Improvement to Decrease Readmission Rates for Patients With a Left Ventricular Assist Device.Prog Transplant. 2018 Jun;28(2):184-188. doi: 10.1177/1526924818765820. Epub 2018 Mar 20. Prog Transplant. 2018. PMID: 29558876 Free PMC article.
-
Self-Care and Compliance with Medication and Their Relationship to the Quality of Life of Patients with Heart Failure.Adv Exp Med Biol. 2023;1425:417-427. doi: 10.1007/978-3-031-31986-0_40. Adv Exp Med Biol. 2023. PMID: 37581815
-
Designing and Testing a Treatment Adherence Model Based on the Roy Adaptation Model in Patients With Heart Failure: Protocol for a Mixed Methods Study.JMIR Res Protoc. 2019 Jul 26;8(7):e13317. doi: 10.2196/13317. JMIR Res Protoc. 2019. PMID: 31350842 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous